Last edition
News about "Lurbinectedin clinical trial"
UK MHRA Approves Lurbinectedin for Extensive-Stage SCLC
The UK MHRA has approved lurbinectedin for adults with extensive-stage Small Cell Lung Cancer, with its safety and effectiveness to remain under close review.
Lurbinectedin Clinical Trial | 25/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members